ZEVRA THERAPEUTICS, INC. business relationships
Companies named in ZEVRA THERAPEUTICS, INC.’s 10-K filed 2026-03-09, and public companies whose annual reports name ZEVRA THERAPEUTICS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 5 / 100 Top 3% in its category
- Agent readiness
- 60 / 100
- AI adoption
- 0 / 100
Named in ZEVRA THERAPEUTICS, INC.’s annual report 3
“We have exclusively licensed from Assistance Publique-Hôpitaux de Paris (AP-HP) a now-issued U.S. patent (US 11,523,997) titled "Method of Providing Celiprolol Therapy to a Patient," with an expiration date in November 2038, excluding any potential patent term extension, which covers certain methods...” SEC filing
“In connection with the AZSTARYS License Agreement, the Company pays Aquestive Therapeutics, Inc. ("Aquestive") a royalty equal to 10 % of all regulatory milestone and royalty payments.” SEC filing
“Corium Inc. was tasked by Commave to lead all commercialization activities for AZSTARYS under the AZSTARYS License Agreement.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.